Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 8585 [06-1478]

Download as PDF 8585 Federal Register / Vol. 71, No. 33 / Friday, February 17, 2006 / Notices Trans No. Acquiring Acquired Entities 20060462 ......................... Southern Union Company ................. SRCG, Ltd ......................................... 20060473 ......................... 20060475 ......................... 20060486 ......................... FMR Corp .......................................... FMR Corp .......................................... ProAssurance Corporation ................ 20060504 ......................... 20060525 ......................... Danaher Corporation ......................... Danaher Corporation ......................... Laird Norton Company LLC .............. Pro-Build Holdings, Inc ...................... Physicians Insurance Company of Wisconsin, Inc. First Technology PLC ........................ First Technology PLC ........................ Richardson Energy Marketing, Ltd., Sid Richardson Energy Services, Ltd. Lanoga Corporation. Pro-Build Holdings, Inc. Physicians Insurance Company of Wisconsin, Inc. First Technology PLC. First Technology PLC. FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative, or Renee Hallman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H– 303, Washington, DC 20580, (202) 326– 3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 06–1503 Filed 2–16–06; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary sroberts on PROD1PC70 with NOTICES Notice of Meeting: Secretary’s Advisory Committee on Genetics, Health, and Society Pursuant to Public Law 92–463, notice is hereby given of the ninth meeting of the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS), U.S. Public Health Service. The meeting will be held from 9 a.m. to 5 p.m. on March 27, 2006 and 9 a.m. to 5 p.m. on March 28, 2006 at the National Institutes of Health, Building 31, C Wing, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. The meeting will be open to the public, with attendance limited to space available. The meeting will be Webcast. The first day of the meeting will include sessions on pharmacogenomics and large population studies of genetic variation, the environment and common disease. The pharmacogenomics session will include a review of Federal efforts in pharmacogenomics and deliberation on draft recommendations in this area. The large population studies session will involve discussion of a draft report that identifies policy issues associated with mounting a large population study in the United States. The second day will be devoted to sessions on genetic discrimination and patents and licensing issues. The genetic discrimination session will include an update on the status of VerDate Aug<31>2005 18:51 Feb 16, 2006 Jkt 208001 Federal genetic non-discrimination legislation. The patents and licensing session will involve a presentation on the findings and conclusions of a National Academy of Sciences’ report on intellectual property rights in genomic research and innovation, and a discussion of whether there are other issues in this arena that warrant SACGHS’s further attention. Time will be provided each day for public comments. The Committee would welcome hearing from anyone wishing to provide public comment on any issue related to genetics, health and society. Individuals who would like to provide public comment or who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at 301–496–9838 or e-mail at sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Under authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established SACGHS to serve as a public forum for deliberations on the broad range of human health and societal issues raised by the development and use of genetic technologies and, as warranted, to provide advice on these issues. The draft meeting agenda and other information about SACGHS, including information about access to the Webcast, will be available at the following Web site: https:// www4.od.nih.gov/oba/sacghs.htm. Dated: February 9, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–1478 Filed 2–16–06; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS Office of the Secretary, Office of Public Health and Science, Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the Presidential Advisory Council on HIV/AIDS (PACHA) will hold a meeting. This meeting is open to the public. A description of the Council’s functions is included also with this notice. DATE AND TIME: March 16, 2006, 8 a.m. to 5 p.m., and March 17, 2006, 8 a.m. to 4 p.m. ADDRESSES: Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201, in Room 800. FOR FURTHER INFORMATION CONTACT: Dana Ceasar, Program Assistant, Presidential Advisory Council on HIV/ AIDS, Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Room 351F, Washington, DC 20201; (202) 690–2470 or visit the Council’s Web site at https://www.pacha.gov. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to (a) promote effective prevention of HIV disease, (b) advance research on HIV and AIDS, and (c) promote quality services to persons living with HIV disease and AIDS. PACHA was established to serve solely as an advisory body to the Secretary of Health and Human Services. The Council is composed of not more than 21 members. Council membership is E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 71, Number 33 (Friday, February 17, 2006)]
[Notices]
[Page 8585]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-1478]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Notice of Meeting: Secretary's Advisory Committee on Genetics, 
Health, and Society

    Pursuant to Public Law 92-463, notice is hereby given of the ninth 
meeting of the Secretary's Advisory Committee on Genetics, Health, and 
Society (SACGHS), U.S. Public Health Service. The meeting will be held 
from 9 a.m. to 5 p.m. on March 27, 2006 and 9 a.m. to 5 p.m. on March 
28, 2006 at the National Institutes of Health, Building 31, C Wing, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892. The meeting 
will be open to the public, with attendance limited to space available. 
The meeting will be Webcast.
    The first day of the meeting will include sessions on 
pharmacogenomics and large population studies of genetic variation, the 
environment and common disease. The pharmacogenomics session will 
include a review of Federal efforts in pharmacogenomics and 
deliberation on draft recommendations in this area. The large 
population studies session will involve discussion of a draft report 
that identifies policy issues associated with mounting a large 
population study in the United States.
    The second day will be devoted to sessions on genetic 
discrimination and patents and licensing issues. The genetic 
discrimination session will include an update on the status of Federal 
genetic non-discrimination legislation. The patents and licensing 
session will involve a presentation on the findings and conclusions of 
a National Academy of Sciences' report on intellectual property rights 
in genomic research and innovation, and a discussion of whether there 
are other issues in this arena that warrant SACGHS's further attention.
    Time will be provided each day for public comments. The Committee 
would welcome hearing from anyone wishing to provide public comment on 
any issue related to genetics, health and society. Individuals who 
would like to provide public comment or who plan to attend the meeting 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the SACGHS Executive 
Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or e-mail at 
sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive, 
Suite 750, Bethesda, MD 20892.
    Under authority of 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established SACGHS to serve as a public forum for deliberations on the 
broad range of human health and societal issues raised by the 
development and use of genetic technologies and, as warranted, to 
provide advice on these issues. The draft meeting agenda and other 
information about SACGHS, including information about access to the 
Webcast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.

    Dated: February 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1478 Filed 2-16-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.